Back to trial detailsIntake questionnaire
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
Applying to Barrow Neurological Institute · Phoenix, Arizona
Answer a few short questions to share with the research team.
0 of 3 answered